CN Patent

CN110934829B — 一种阿瑞吡坦的纳米胶束

Assigned to Fubicheng Shanghai Pharmaceutical Technology Co ltd · Expires 2021-10-01 · 5y expired

What this patent protects

本发明提供了一种阿瑞吡坦纳米胶束制剂，该胶束制剂包括阿瑞吡坦、磷脂、蔗糖、乙醇和注射用水，其中磷脂包含磷脂酰胆碱和磷脂酰甘油。本发明注射剂具有更好的物理和化学稳定性，使药物质量更易于控制，工艺更简化，临床用药更加安全，成本更低，提高了药物的可及性。

USPTO Abstract

本发明提供了一种阿瑞吡坦纳米胶束制剂，该胶束制剂包括阿瑞吡坦、磷脂、蔗糖、乙醇和注射用水，其中磷脂包含磷脂酰胆碱和磷脂酰甘油。本发明注射剂具有更好的物理和化学稳定性，使药物质量更易于控制，工艺更简化，临床用药更加安全，成本更低，提高了药物的可及性。

Drugs covered by this patent

Patent Metadata

Patent number
CN110934829B
Jurisdiction
CN
Classification
—
Expires
2021-10-01
Drug substance claim
No
Drug product claim
No
Assignee
Fubicheng Shanghai Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.